Chemocentryx Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHEMOCENTRYX, and when can generic versions of CHEMOCENTRYX drugs launch?
CHEMOCENTRYX has one approved drug.
There are four US patents protecting CHEMOCENTRYX drugs.
There are ninety patent family members on CHEMOCENTRYX drugs in thirty-seven countries and ten supplementary protection certificates in ten countries.
Drugs and US Patents for Chemocentryx
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemocentryx | TAVNEOS | avacopan | CAPSULE;ORAL | 214487-001 | Oct 7, 2021 | RX | Yes | Yes | 11,951,214 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Chemocentryx | TAVNEOS | avacopan | CAPSULE;ORAL | 214487-001 | Oct 7, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Chemocentryx | TAVNEOS | avacopan | CAPSULE;ORAL | 214487-001 | Oct 7, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Chemocentryx Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Serbia | 54998 | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2020112961 | ⤷ Sign Up |
Brazil | 112022007489 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Chemocentryx Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3508477 | PA2022006 | Lithuania | ⤷ Sign Up | PRODUCT NAME: AVAKOPANAS IR JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS ; REGISTRATION NO/DATE: EU/1/21/1605 20220111 |
2381778 | 17/2022 | Austria | ⤷ Sign Up | PRODUCT NAME: AVACOPAN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES; REGISTRATION NO/DATE: EU/1/21/1605 (MITTEILUNG) 20220119 |
2381778 | CA 2022 00022 | Denmark | ⤷ Sign Up | PRODUCT NAME: AVACOPAN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REG. NO/DATE: EU/1/21/1605 20220119 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.